國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG)
0.1.0 - trial-use

This page is part of the 國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG) (v0.1.0: Releases) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

ValueSet: 申報醫院化學治療值集

Official URL: https://www.ghd.tw/cdm-fhir/fhir/ValueSet/CRLF-Chem-DH Version: 0.1.0
Active as of 2024-09-01 Computable Name: CRLFChemDHValueSet

CRLF申報醫院化學治療值集

References

Logical Definition (CLD)

Generated Narrative: ValueSet CRLF-Chem-DH

 

Expansion

Generated Narrative: ValueSet

Expansion based on codesystem 申報醫院化學治療代碼系統 v0.1.0 (CodeSystem)

This value set contains 25 concepts

CodeSystemDisplay
  00https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH(1)未接受化學治療，化學治療非首次療程的一部份 (2)由屍體解剖時才診斷為癌症
  01https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH接受全身性化學治療
  02https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH接受全身性化學治療，且只有一種化學藥物。(僅適用於 2017(含)診斷年之前的個案)
  03https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH接受全身性化學治療，且超過一種以上的化學藥物。(僅適用於 2017(含)診斷年之前 的個案)
  04https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH個案原發部位僅接受局部動脈栓塞化學治療(TACE)
  05https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH個案原發部位接受局部動脈栓塞化學 (TACE)及全身性化學治療
  06https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH個案原發部位接受局部動脈栓塞化學 (TACE)及其他局部性化學治療
  07https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH個案原發部位接受局部動脈栓塞化學 (TACE)、其他局部性及全身性化學治療
  08https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH個案僅接受局部性化學治療(不包含TACE) (1)肋膜腔注射 (2)心包膜腔注射 (3)腹腔內注射 (4)膀胱灌注 (5)脊髓腔內注射(intrathecal) (6)其他局部化學治療(例如：BCNU wafer implantation)
  09https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH個案同時接受全身性及局部性化學治療(不包含TACE)
  10https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH肝轉移個案接受局部動脈栓塞化學治療(TACE)
  11https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH肝轉移個案接受局部動脈栓塞化學(TACE)及全身性化學治療
  12https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH肝轉移個案接受局部動脈栓塞化學治療(TACE)及其他局部性化學治療
  13https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH肝轉移個案接受局部動脈栓塞化學治療(TACE)、其他局部性及全身性化學治療
  20https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH僅接受臨床試驗化學治療
  21https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH同時接受化學治療(全身性或/與局部性)及臨床試驗化學治療
  30https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH僅接受雙盲試驗化學治療
  31https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH同時接受化學治療(全身性或/與局部性)及雙盲試驗化學治療
  82https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH化學治療因禁忌症或個案其他危險因素(併發症、年邁)而未建議或給予
  83https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH化學治療因疾病進展而未建議或給予
  85https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH化學治療是既定之首次療程計畫中的一部分，但因個案未接受治療前即死亡或病危出院
  86https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH化學治療雖然是既定之首次療程計畫中的一部分，未執行且病歷並未記載未執行的原因；或於他院執行化學治療
  87https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH化學治療雖然是既定之首次療程計畫中的一部分，但未執行，且病歷記載個案或其家屬拒絕此項治療
  88https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH化學治療雖是既定之首次療程計畫中的一部分，但摘錄時尚未執行
  99https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH(1)由於病歷未記載，所以不知道化學治療是否有被建議或是已經執行 (2)僅由死亡證明書得知個案有癌症

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code